Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic levetiracetam before glioma surgery for seizure prevention
ISRCTN70051203Phase 3Completed
- Sponsor
- Public Health Scotland
- Start
- Jul 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of levetiracetam in glioma (2 arms), sponsored by Public Health Scotland. Primary endpoint: Number of patients developing seizures. Started Jul 2019; status: completed.
02
Drugs
levetiracetam
03
Conditions
glioma
Beyond the preview
Go deeper on ISRCTN70051203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70051203.